A randomized phase 3 trial of interferon-α vs hy... - MPN Voice

MPN Voice

10,886 members15,202 posts

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

LongETinUS profile image
9 Replies

Hello

The paper below recently came out in May. I thought member would be interested. Apologies if this is old news.

“A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia”

It is freely downloadable from PubMed at

pubmed.ncbi.nlm.nih.gov/350...

The front page lists the key points as

1) Rates of thrombosis and progression were low in patients with ET/PV treated with either HU or IFN in this randomized study.

2) PEG was more effective in normalizing counts and reducing JAK2V617F VAF in PV whereas HU induced more HPRs in ET.

Written by
LongETinUS profile image
LongETinUS
To view profiles and participate in discussions please or .
Read more about...
9 Replies
Lin_Hsu profile image
Lin_Hsu

I also share an article about 6 years of HU or ropeginterferon alpha-2b treatment.

Aims:To analyze the patient-relevant benefit of ropeginterferon alfa-2b versus hydroxyurea (HU)/best available treatment (BAT) over 6 years.

library.ehaweb.org/eha/2022...

EPguy profile image
EPguy in reply toLin_Hsu

This one is good results, I've been sharing some info from it. I hope they provide the full text eventually. This plot sums it up well. Ropeg had less progression esp after many years.

RopegEventFree6years
monarch5000 profile image
monarch5000

Silver MPN Center in New York City findings:

"20 years after diagnosis, 85% of PV patients who had been treated with interferon had not progressed to MF compared to 59% for the HU group and 51% of the phebotomy-only group."

"overall survival for patients on interferon was 95% compared to 63% for HU and 57% for phlebotomy-only."

EPguy profile image
EPguy in reply tomonarch5000

That study I think is one reason for the recent revival of INF for MPN. Here is a plot from it that shows it well. The blue line is INF.

LongTermINF
Bluetop profile image
Bluetop in reply tomonarch5000

Thanks for this. I'm assuming this one relates to peg interferon?

EPguy profile image
EPguy in reply toBluetop

It was actually for the older non-peg formulation from the description. That seems reasonable since pegintron or pegasys were not available in the early part of these studies. Could be the later portions of the study were with peg.

healthunlocked.com/mpnvoice...

Bluetop profile image
Bluetop in reply toEPguy

Oh yes, thanks.

EPguy profile image
EPguy

I've not seen this specific one, thanks. It's consistent on thrombotic events, I recall most studies don't find a big diff between HU and INF. But for allele (AB) it is too short duration, INF needs longer periods (than 24 months) to show its best effects.

But it is consistent at 2 years (Fig 3) showing HU losing its AB effect while INF is just getting started, we see this in almost all such studies.

Bluetop profile image
Bluetop

Thanks very much for posting. It is very interesting -the team involved, the fact they are looking at pegasus, not ropeg and the results.

Not what you're looking for?

You may also like...

Phase 3, Trial of Interferon-α versus Hydroxyurea in Polycythemia Vera and Essential Thrombocythemia

Key Points Rates of thrombosis and progression were low in patients with ET/PV treated with either...
Manouche profile image

Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach

 »In regard to PV, the decision to introduce cytoreduction may be more understandable than in ET....
Manouche profile image

Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

« Several lines of evidence suggest other factors contribute to the propensity to develop...
Manouche profile image

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia

Conclusions These findings suggest that it may be important to incorporate statins into the...
Manouche profile image

Recombinant Interferon-β in the Treatment of Polycythemia Vera

 Simple Summary: « The myeloproliferative neoplasms (MPNs) are chronic blood cancers...
Manouche profile image